Preclinical
DCprime today announced presentations of additional preclinical data sets for its lead program, DCP-001, at the 7th CCBIO Annual Symposium and the 2019 CIMT Annual Meeting.
A systemically injectable peptide, which may make it possible to restore lost functions in spinal cord injury patients, is moving toward clinical trials in early 2020. It has seen success in animal models.
Medigene AG announced that the Company’s strategic partner bluebird bio, Inc. (NASDAQ:BLUE), USA, at its analyst day presentation, will present preclinical data of the first therapeutic T cell receptor (TCR) candidate resulting from the research and development partnership with Medigene.
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.
Today has been marked by a wide range of life science and biopharma stories. Here’s a broader look at some of the top stories.
Study shows how imipridone drugs ONC201 and ONC212 cause cancer cell death
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.
Pharma, biotech and life science companies from across the globe share data and progress on pipelines and other company events.
Are you fascinated with microbiology? Have you ever thought about how to integrate your passion for research and entrepreneurship? The field of microbiology is expanding and being significantly impacted by advancements in technology.
The Christiana Care Health System’s Gene Editing Institute, based in Wilmington, Del., is pulling together a preliminary investigational new drug application (IND) for the U.S. Food and Drug Administration (FDA).
PRESS RELEASES